Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Trecondyv by Medac for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval
Trecondyv is under clinical development by Medac and currently in Pre-Registration for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia). According...
Data Insights
Trecondyv by Medac for Myelodysplastic Syndrome: Likelihood of Approval
Trecondyv is under clinical development by Medac and currently in Pre-Registration for Myelodysplastic Syndrome. According to GlobalData, Pre-Registration drugs for...